According to this hypothesis, circulating inflammation mediators such as TNF-α and IL-18 that are strongly implicated with endothelial dysfunction and cardiovascular disease [28–30] might induce vascular damage and exacerbate the atherosclerotic burden leading to higher cardiovascular morbidity and mortality that is seen in AF subjects [1]. This evidence concerns the gene IL18 and endothelial dysfunction.